Cargando…
(18)F-Fluoride PET/CT tumor burden quantification predicts survival in breast cancer
PURPOSE: In bone-metastatic breast cancer patients, there are no current imaging biomarkers to identify which patients have worst prognosis. The purpose of our study was to investigate if skeletal tumor burden determined by (18)F-Fluoride PET/CT correlates with clinical outcomes and may help define...
Autores principales: | Brito, Ana E., Santos, Allan, Sasse, André Deeke, Cabello, Cesar, Oliveira, Paulo, Mosci, Camila, Souza, Tiago, Amorim, Barbara, Lima, Mariana, Ramos, Celso D., Etchebehere, Elba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482633/ https://www.ncbi.nlm.nih.gov/pubmed/28415595 http://dx.doi.org/10.18632/oncotarget.16418 |
Ejemplares similares
-
Is interim (18)F-fluoride PET/CT a predictor of outcomes
after radium-223 therapy?
por: Etchebehere, Elba, et al.
Publicado: (2019) -
Proposal for a Quantitative (18)F-FDG PET/CT Metabolic Parameter to Assess the Intensity of Bone Involvement in Multiple Myeloma
por: Takahashi, Maria E. S., et al.
Publicado: (2019) -
Interictal and postictal (18)F-FDG PET/CT in epileptogenic
zone localization
por: Carvalho, Marcela Santos, et al.
Publicado: (2022) -
(99m)Tc-sestamibi SPECT/CT and (18)F-FDG-PET/CT have similar performance but different imaging patterns in newly diagnosed multiple myeloma
por: Mosci, Camila, et al.
Publicado: (2020) -
(18)F-fluoride PET/CT in clinical practice
por: Ramos, Celso Darío
Publicado: (2015)